| Rheumatic: Epidemiology, Pathogenesis, and Prevention of Acute Rheumatic Fever and Rheumatic Heart Disease | |
|---|---|
| 13:30 – 13:50 | Novel immunological aspects in Acute Rheumatic Fever Luisa Guilherme, Brazil |
| 13:50 – 14:10 | Genetic Susceptibility to Rheumatic Heart Disease Tom Parks, UK |
| 14:10 – 14:30 | Vaccine against RF current status and future hope Andrew Steer, Australia |
| 14:30 – 14:50 | Penicillin: forms, supply, safety and frequency Masood Sadiq, Pakistan |
| 14:50 – 15:10 | RHD registries: lessons from successful registry systems Nigel Wilson, New Zealand |
| 15:10 – 15:30 | Discussion |
| Rheumatic: Diagnosis and treatment of acute rheumatic fever (ARF) and rheumatic heart disease (RHD) | |
|---|---|
| 10:00 – 10:20 | Physicians, health care workers, and the public: how to teach about ARF and RHD? Alyaa Kotby, Egypt |
| 10:20 – 10:40 | Echocardiographic cases of RHD and their differential diagnosis Ercan Tutar, Turkey |
| 10:40 – 11:00 | Rheumatic heart disease in pregnancy Andrea Beaton, US |
| 11:00 – 11:20 | Access to catheterization for RHD patients in low-income countries Emmy Okello, Uganda |
| 11:20 – 11:40 | Mitral valve repair and replacement for RHD Manuel Antunes, Portugal |
| 11:40 – 12:00 | Postoperative anticoagulation: safety and sustainability Joseph Mocutsibi, Rwanda |
| Imaging, Rheumatic, and Kawasaki Bridging Together Session | |
|---|---|
| 13:30 – 13:50 | Rheumatic Fever Tom Gentles, New Zealand |
| 13:50 – 14:10 | Kawasaki Disease Isao Shiraishia, Japan |
| 14:10 – 14:30 | Coronary artery lumen and vessel wall imaging in children - how and when to use echo, MR, CT, or other modalities Gerald Greil, US |
| 14:30 – 14:50 | Latest ARF Guidelines: how and when to use echo, MR, CT, or other modalities Boglarka Remenyi, Australia |
| 14:50 – 15:10 | Making Screening for RHD Practical in Low and Middle Income Countries: Technology & Task Shifting Andrea Beaton, US |
| 15:10 – 15:30 | Global burden of Rheumatic Heart Disease (RHD): Lessons learned from echocardiography-based screeing Liesl Zuhlke, South Africa |
| Rheumatic: Oral Abstracts and Keynote Addresses | |
|---|---|
| 10:00 – 11:00 | Abstracts: 4 (15 min per abstract) |
| 11:00 – 11:30 | Keynote 1: Eradication of Rheumatic Heart Disease (RHD): A reality - RHD should be a disease of the past Liesl Zuhlke, South Africa |
| 11:30 – 12:00 | Keynote 2: Surgery for RHD- the need, the outcomes and the future Arkalgud Sampathkumar, India |
| Rheumatic: Acute Rheumatic Fever and Rheumatic Heart Disease: Controversies and Hope | |
|---|---|
| 13:30 – 13:50 |
Primary prevention (strep treatment) holds best hope for eradication of RHD
|
| 13:50 – 14:10 |
Echo screening/secondary prevention holds best hope for eradication of RHD
|
| 14:10 – 14:30 |
Ideal ARF Criteria are the 2015 Jones Criteria
|
| 14:30 – 14:50 | Implementing a comprehensive RHD control program Sulafa Ali, Sudan |
| 14:50 – 15:10 | Patients, advocacy groups and global action initiatives Ann Olga Mocumbi, Mozambique |
| 15:10 – 15:30 | Discussion |